D Nagel

发表

Alkaline phosphatase isoenzymes in detection and follow up of breast cancer metastases.

M Untch, W Eiermann, P Stieber, 1998, Anticancer research.

CYFRA 21‐1: A new marker in lung cancer

H Dienemann, P. Stieber, D. Nagel, 1993, Cancer.

Systematically missing confounders in individual participant data meta-analysis of observational cohort studies

H Tunstall-Pedoe, Dan Jackson, S G Thompson, 2009, Statistics in medicine.

Early detection of metastatic disease in asymptomatic breast cancer patients with whole-body imaging and defined tumour marker increase

G. Schmidt, V. Heinemann, P. Stieber, 2015, British Journal of Cancer.

Serum CEA and CA 15-3 as prognostic factors in primary breast cancer

M. Untch, G. Konecny, P. Stieber, 2002, British Journal of Cancer.

Tumour markers CEA and CA 15-3 as Prognostic factors in breast cancer--univariate and multivariate analysis.

M. Untch, P. Stieber, D. Nagel, 1999, Anticancer research.

The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases

H Tunstall-Pedoe, V Tikhonoff, A Hofman, 2007, European Journal of Epidemiology.

Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population

K Nikolaou, C. Becker, A. Graser, 2008, Gut.

Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.

H Tunstall-Pedoe, Simon G Thompson, John Danesh, 2005, JAMA.

Cluster analysis in diagnosis.

D. Nagel, W. Vogt, W Vogt, 1992, Clinical chemistry.